In The Media

Copy of Sheller Risperdal Supreme Court Banner

Fed up with corporate misuse of bankruptcy laws to skirt responsibility to their victims while keeping their fortunes, Democrats announce the Nondebtor Release Prohibition Act of 2021. The Nondebtor Release Prohibition Act of
pharmacy 2 250x250

New York federal Judge Robert Drain moves negotiations forward for Purdue Pharma in the most complicate and controversial bankruptcy trial. More than twelve states, the DOJ, and multiple attorney generals object to the
Wall Ball 4

Stephen and Sandy Sheller were honorary attendees at Mural Arts Philadelphia’s 2021 Wall Ball, The Art of Wellbeing. Held virtually June 10, 2021 at 6:00 pm. The Sheller’s have been a long time
Risperdal green tablet

Johnson & Johnson is out of options after the U.S. Supreme Court declined to hear the pharmaceutical company’s appeal of a $70 million Risperdal verdict. In the cases of Yount vs. Janssen Pharmaceuticals,
medical malpractice

When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud. Recently Wells Fargo bank made headlines when bank
Screen Shot 2021-03-04 at 5.53.04 PM

2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
DOJ Emblem

With the Biden administration taking the White House last month, the new administration has been vocal about enforcing antitrust and fraud laws, especially as it pertains to those who took advance of federal
DOJ Emblem

Purdue Pharma pleads guilty to criminal charges for illegal marketing of the its highly addictive painkiller, OxyContin. Corporations often pay penalties and fines for wrongdoing, yet criminal charges are rare. These charges include
Risperdal green tablet

The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen Pharmaceuticals,
Lilly bldg credit turner 615x438.jpb

A DC Circuit court upheld a federal judge’s ruling striking down the Department of Health and Human Services’ new rule requiring drug companies to disclose the price of a 30 day supply in